Search

everythinglearnresearchcommunity

for

Search:↓

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Scientists found cells in hair that are key for growth and color.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Isotretinoin is safe and effective for acne, with common side effects like dry lips; serious side effects are rare.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Minoxidil and ATRA together boost hair growth more effectively than minoxidil alone.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Some alternative treatments for hair loss might work, but more research is needed.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Understanding how EDC genes are regulated can help develop better drugs for skin diseases.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Melatonin solution helps treat hair loss in men and women.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Adrenal disorders can cause lasting brain and behavior issues in children.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Two patients with porphyria cutanea tarda experienced their grey hair turning dark again.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.